94 related articles for article (PubMed ID: 21708412)
21. Long-term safety and efficacy of sirolimus- vs. paclitaxel-eluting stent implantation for acute ST-elevation myocardial infarction: 3-year follow-up of the PROSIT trial.
Kim HS; Lee JH; Lee SW; Kim YH; Park JH; Choi SW; Jeong JO; Seong IW; Rhee KS; Ko JK; Jo SH; Choi YJ
Int J Cardiol; 2011 Mar; 147(2):253-7. PubMed ID: 19783056
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.
Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ
J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303
[TBL] [Abstract][Full Text] [Related]
23. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.
Park KW; Chae IH; Lim DS; Han KR; Yang HM; Lee HY; Kang HJ; Koo BK; Ahn T; Yoon JH; Jeong MH; Hong TJ; Chung WY; Jo SH; Choi YJ; Hur SH; Kwon HM; Jeon DW; Kim BO; Park SH; Lee NH; Jeon HK; Gwon HC; Jang YS; Kim HS
J Am Coll Cardiol; 2011 Oct; 58(18):1844-54. PubMed ID: 22018294
[TBL] [Abstract][Full Text] [Related]
24. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL
Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585
[TBL] [Abstract][Full Text] [Related]
25. Coronary artery lesions in Takayasu's arteritis--clinical and angiographic study.
Panja M; Sarkar C; Kar AK; Kumar S; Mazumder B; Roy S; Sinha DP; Sarkar NC
J Assoc Physicians India; 1998 Aug; 46(8):678-81. PubMed ID: 11229271
[TBL] [Abstract][Full Text] [Related]
26. Stenosis of the main stem of the left coronary artery in a teenager with Takayasu's arteritis.
Reddy SM; Reddy SP
Cardiol Young; 2009 Dec; 19(6):638-40. PubMed ID: 19849872
[TBL] [Abstract][Full Text] [Related]
27. Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.
Stone GW; Kedhi E; Kereiakes DJ; Parise H; Fahy M; Serruys PW; Smits PC
Circulation; 2011 Aug; 124(8):893-900. PubMed ID: 21824922
[TBL] [Abstract][Full Text] [Related]
28. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study.
Saia F; Lemos PA; Lee CH; Arampatzis CA; Hoye A; Degertekin M; Tanabe K; Sianos G; Smits PC; McFadden E; Hofma SH; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
Circulation; 2003 Oct; 108(16):1927-9. PubMed ID: 14557354
[TBL] [Abstract][Full Text] [Related]
29. Successful percutaneous transluminal coronary angioplasty for acute myocardial infarction in a 12-year-old boy with fibromuscular dysplasia: a case report.
Lin MC; Lee WL; Fu YC
Cardiol Young; 2015 Jan; 25(1):177-80. PubMed ID: 24438390
[TBL] [Abstract][Full Text] [Related]
30. Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry.
Tada T; Kimura T; Morimoto T; Ono K; Furukawa Y; Nakagawa Y; Nakashima H; Ito A; Siode N; Namura M; Inoue N; Nishikawa H; Nakao K; Mitsudo K;
Am J Cardiol; 2011 Apr; 107(8):1155-62. PubMed ID: 21296326
[TBL] [Abstract][Full Text] [Related]
31. Acute myocardial infarction with left main coronary artery ostial negative remodelling as the first manifestation of Takayasu arteritis: a case report.
Zhou S; Gao C; Li F
BMC Cardiovasc Disord; 2021 Nov; 21(1):560. PubMed ID: 34809570
[TBL] [Abstract][Full Text] [Related]
32. Takayasu arteritis with coronary aneurysms causing acute myocardial infarction in a young man.
Ouali S; Kacem S; Ben Fradj F; Gribaa R; Naffeti E; Remedi F; Laaoueni C; Boughzela E
Tex Heart Inst J; 2011; 38(2):183-6. PubMed ID: 21494533
[TBL] [Abstract][Full Text] [Related]
33. Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction.
Pierre-Louis B; Aronow WS; Palaniswamy C; Singh T; Ahn C; Asija A; Weiss MB; Kalapatapu K; Pucillo AL; Monsen CE
Am J Cardiol; 2009 Jun; 103(12):1672-4. PubMed ID: 19539074
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of sirolimus-eluting stent implantation in patients with acute coronary syndrome in the real world.
Kawaguchi R; Kimura T; Morimoto T; Oshima S; Hoshizaki H; Kawai K; Shiode N; Hiasa Y; Mitsudo K;
Am J Cardiol; 2010 Dec; 106(11):1550-60. PubMed ID: 21094354
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
36. [Takayasu's disease as the cause of myocardial infarct in an infant].
Vos GD; van der Blij JF; van Leeuwen TM; Losekoot G
Ned Tijdschr Geneeskd; 1987 Aug; 131(31):1355-7. PubMed ID: 2889149
[No Abstract] [Full Text] [Related]
37. Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: a report from the national cardiovascular data registry.
Wang TY; Peterson ED; Ou FS; Nallamothu BK; Rumsfeld JS; Roe MT
Am Heart J; 2011 Jan; 161(1):76-83.e1. PubMed ID: 21167337
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy comparison of primary percutaneous coronary intervention with biodegradable polymer- and durable polymer-based sirolimus-eluting stents for patients with acute myocardial infarction].
Li Q; Wang LF; Yang XC; Ge YG; Wang HS; Li WM; Xu L; Ni ZH; Xia K
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Oct; 38(10):886-90. PubMed ID: 21176630
[TBL] [Abstract][Full Text] [Related]
39. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B
N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989
[TBL] [Abstract][Full Text] [Related]
40. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
Chong E; Poh KK; Liang S; Lee RC; Low A; Teo SG; Tan HC
J Interv Cardiol; 2010 Apr; 23(2):101-8. PubMed ID: 20236214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
